Since cancer immunotherapy was declared the Breakthrough of the Year in 2013 by Science magazine the field has been on fire, and its relatively few experts have been on the run– explaining the nascent technology and related data to oncologists at...
Via Krishan Maggon
The overall message is clear: cancer immunotherapy is here to stay. It’s effective, and it’s sexy: as Jedd Wolchok, M.D., Ph.D., of the Memorial Sloan Kettering Cancer Center, said at ASCO, “We treat the patient. It’s the patient that treats the tumor.”